Search
Dr Amarnath Challapalli

Dr Amarnath Challapalli

Clinical oncology 06031215

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Skin
  • Urology

Offers

  • Face-to-face consultations
  • Video and telephone consultations
  • Home chemotherapy

About me

Dr. Amarnath Challapalli is a Consultant Clinical Oncologist at Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust specialising in the management of urological cancers and non-melanomatous skin cancer with radiotherapy, chemotherapy and immunotherapy. He chairs the clinical governance committee at the Bristol Cancer Institute and is a member of the Medicines advisory group (MAG). He organises and lectures in the skin cancer study day for the Royal College of Radiologists and is a faculty member on other courses for the college. He is also a panel member of Mirrors in Medicine, an International Case-based professional development platform. This panel pinpoints important clinical topics and provide a concise summary of evidence from clinical studies and guidelines. He also lectures on various topics both at regional and national level.
Dr. Challapalli undertook his medical and postgraduate training in clinical oncology in India and in the UK, achieving Fellowship of the Royal College of Radiologists. He subsequently completed a PhD at Imperial College, London in January 2014. His research focused on the translation of novel PET tracers looking at cell proliferation, apoptosis and choline metabolism into clinical studies to look at early response assessment to treatment. He is the UK Chief Investigator for the adjuvant Cemiplimab trial in high risk squamous cell carcinoma and a Co-Chief Investigator of the national multicentre ACE trial. His work has been published in peer-reviewed journals and presented at national and international meetings.

Areas of interest

prostate cancer; bladder cancer; renal cancer; penile cancer; testicular cancer radiotherapy; nonmelanoma skin cancers.

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

  • X6930

    Clinical supervision of the planning of a course of complex radiotherapy - (1-5)

  • AA843

    Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-21 days - (1-5)

  • X0007

    Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)

  • X0008

    Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.